Markets

Market Nav

News Details

13/05/2025 11:54

Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Lupin Launches Tolvaptan Tablets in the U.S. with 180-Day Exclusivity.